Moderna said a new vaccine to tackle the Omicron COVID-19 variant could be ready by early 2022 if it is needed. Moderna’s chief medical officer, Dr.
Paul Burton, said in an interview on BBC’s Andrew Marr Show that if a new vaccine is necessary, “I think that’s going to be early 2022 before that’s really going to available in large quantities.” “The remarkable thing about the mRNA vaccines, Moderna platform is we can move very fast,” he said, noting that the company started work on an Omicron vaccine on Thursday, during the U.S.’s Thanksgiving holiday. Read more: Netherlands, Australia confirm cases of Omicron COVID-19 variant Burton said Moderna should know whether the current COVID-19 vaccine can provide protection against Omicron in